British American Tobacco (BTI) Buy, Sell or…

Home

Daily Stock Opinions and Ratings

British American Tobacco (BTI)

59.72

+1.87 (3.23%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

95 watching

Investor Insights

Jun 6, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

British American Tobacco (BTI-N) has experienced a significant uptick in its stock performance, though experts suggest it may have peaked for the time being, particularly in light of ESG concerns. The company recently announced organic revenue growth expectations at the upper end of its guidance range, indicating slight improvement, while maintaining conservative estimates for operating profit. As competition heats up and consumer preferences shift, ongoing investment in R&D for next-generation products is crucial, supported by a recovery in traditional cigarette revenue in the U.S. Despite these positive signals, experts caution that the stock's impressive one-year gain of 72% may not be sustainable, recommending that investors consider reducing their holdings while still benefitting from the attractive dividend yield of 5.01%. Overall, while BAT remains a solid choice for income, the long-term outlook carries certain risks, and maintaining a cautious stance may be advisable.

Consensus

Cautious

Valuation

Overvalued

Similar

PM, PM

DON'T BUY

Pass. Doesn't care for tobacco stocks (or vape companies) given the harm they produce to human health.

Wealthica Track your Stocks in your Watch List

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly If you are okay owning tobacco based companies, BTI may be a good entry here. The England based company makes well known brands worldwide and trades at a 10x PE. Pandemic related stress is increasing consumption according to Reuters. The company pays a stellar dividend, backed by a payout ratio of only 26% of cash flow. We would trade this with a $32 stop-loss, looking to achieve a target of $50 -- 28% upside. Yield 7.1% (Analysts’ price target is $50.00)

DON'T BUY

The tobacco space looks cheap but there is a secular overhang. They are highly profitable but eventually, tobacco sales will disappear. ESG is also a force. Institutional investors may not be able to own this.

PAST TOP PICK

(A Top Pick Sep 06/19, Up 7%) Likes the sector. Opportunity now, as it's heavily oversold. Take a look at the category and add a second name.

BUY

Loaded up with debt, small dividend cut, vaping issue, new CEO, plus litigation. What are the underlying fundamentals moving forward? Asia seeing growth. Elsewhere, volumes going down but prices going up. It's a buy and there's some upside.

COMMENT

As a 7-year hold? Investors stay away from tobacco stocks because tobacco causes cancer. Yes, they have a lot of free cash flow and pay big dividends, but he doesn't see huge upside. You buy this for the dividend and a modest stock price rise over time.

BUY

They aren't a big player in the vaping industry. Vaping is more and more court regulated. Debt reduction will occur during 2020-2022. He doesn't see major challenges. He sees more growth and would buy looking at the chart and dividend. He also thinks that they might enter into cannabis and they would be well positioned.

TOP PICK

The long term dividend track record has been great. The recent issues around vaping and health concerns has caused the share price to drop. It acquired the Reynolds business in 2018 and it is doing well. It is very well valued here. Yield 7.55% (Analysts’ price target is $47.22)

Wealthica Track your Stocks in your Watch List

BUY

They carry some debt. Pays a 6.6% dividend. It's underperformed in the past year, because they made a big US acquisition, and the FDA punished and targeted this sector until its bosses changed a few months ago. Ex-dividend, BTI generates $1.5 billion free cash flow, which will pay down debt aggressively. Has a good history of dividend growth. This may not climb immediately, but you can collected the dividend until then. He likes it.

BUY

There has been a sector rotation out of tobacco and staples into the high high-growth type stories. Good entry point.

DON'T BUY

This is the tobacco stock he *would* own if he owned any of them. This is a low-growth industry. There might be a catalyst for growth from heat-not-burn consumption of tobacco but he is looking to invest in companies with more growth opportunities in the fundamental business.

TOP PICK

The 15-year total return on the stock is 9.3X in Cdn$, which is 930%. This is currently on sale, because last year they purchased the remaining portion of Reynolds American that they didn’t own, giving them a bit more debt than normal. A very sticky business model. Dividend yield of 3.4%. (Analysts’ price target is $77.88.)

DON'T BUY

(Market Call Minute) He does not touch companies that addict their customers to deadly products.

COMMENT

He likes sin stocks and particularly likes tobacco. They give you dividend increases of substantial order. He particularly likes this which is effectively a Commonwealth story with the emerging markets. You don’t have much exposure with the US, and as a result, the risk of litigation is much lower. Good story and the dividend is attractive and grows slowly over time. Buy this on the dips, and you will be pretty happy.

BUY

British American Tobacco. Only held by his wife (non-smoker). Favorite tobacco company. Likes the global exposure and the growth possibilities. Would not be surprised to see them someday increase their exposure in the US.

Showing 31 to 45 of 50 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

British American Tobacco (BTI)